The Pratt lab has recently made an exciting discovery regarding posttranslational modifications (PTMs) which is described in their publication in the February 2024 issue of Nature Chemical Biology. Read More
The USC Michelson Center for Convergent Bioscience and Agilent Technologies, Inc. proudly introduce the latest awardees in the Agilent Fellows Program. Dr. Alessandro Coradini and Dr. Matthew Sarnowski have been selected for the fellowship, which provides support for two years of postdoctoral research. The Agilent Fellows Program is now accepting postdoctoral applications for 2023. Read More
An alliance between USC and global research, development and manufacturing company Agilent enables USC researchers to unravel mysteries within individual cells and develop more targeted and personalized treatments. [4½ min read] The post Agilent Postdoctoral Fellow undertakes molecular scrutiny of cells appeared first on News and Events. Read More
Using nano-probes to amplify biochemical signals could lead to targeted, noninvasive treatment of cancer, Fabien Pinaud’s big vision for treating cancer homes in on the smallest of targets. Read More
Charles McKenna of chemistry and Kelvin Davies of biological sciences and gerontology join global experts to discuss oxidative stress phenomena and understand its possible clinical implications. Read More
With six high-profile papers published in the past seven months, biochemists in The Bridge@USC are poised to disrupt the future of pharmaceutical development and enable the advancement of personalized medicine. Read More
New creation could one day be used for demolition of cancer cells. The post Bucky-Balls Become Buckybombs appeared first on News and Events. Read More
New technique allows scientists to ‘see’ how non-addictive painkillers bind to neuroreceptors. Read More
